Kanvas Biosciences
PrivateLast Round
Series A
May 6, 2026
Total Funding Raised
$72.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Kanvas Biosciences operates in Healthcare & Life Sciences and is based in Princeton, New Jersey. Its latest recorded funding round was a Series A round in May 2026.
Kanvas Biosciences is a spatial biology company that develops microbiome drug screening, discovery, and manufacturing platforms to accelerate the development of next-generation live biotherapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kanvas Biosciences Comparables
Compare Kanvas Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Microbiotica | 78% | |
| Concerto Biosciences | 77% | |
| Enterome | 76% |
For institutional investors. Book with your work email.
Kanvas Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 6, 2026 | ||||
| Seed | Jul 1, 2024 | ||||
| Pre Seed | Jun 22, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kanvas Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zeon Ventures | Series A |
| Kicker Ventures | Series A |
| Gaingels | Series A |
| Triple Impact Capital | Series A, Pre Seed |
| Uncommon Denominator | Series A, Pre Seed |
| Athos KG | Series A |
| Germin8 Ventures | Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 71% MoM, from 3.4K to 5.8K.
- Aug 21, 2026
Monthly visitors increased 53% MoM.
For institutional investors. Book with your work email.
Kanvas Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kanvas Biosciences's valuation, stock price, and market status.
Is Kanvas Biosciences a public or private company?
Kanvas Biosciences is a private company.
What is the current stock price of Kanvas Biosciences?
Kanvas Biosciences is a private company, so its shares have no public market price. Caplight tracks Kanvas Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kanvas Biosciences worth (valuation)?
Valuation information for Kanvas Biosciences is not publicly available.
Can I buy Kanvas Biosciences stock?
Kanvas Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kanvas Biosciences's last funding round?
Kanvas Biosciences's most recent funding round was Series A on May 6, 2026.
Who are the main investors in Kanvas Biosciences?
Key investors in Kanvas Biosciences include Lion Capital, Lions Capital LLC, Lions Capital LLC, DCVC (Data Collective).
Will Kanvas Biosciences IPO soon?
No public IPO plans have been announced for Kanvas Biosciences.
How can I track Kanvas Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Kanvas Biosciences's shares on secondary markets.